Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene - PubMed (original) (raw)
. 2009 Jul;55(7):1406-14.
doi: 10.1373/clinchem.2008.122564. Epub 2009 May 21.
Affiliations
- PMID: 19460837
- DOI: 10.1373/clinchem.2008.122564
Free article
Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene
Sharon D Whatley et al. Clin Chem. 2009 Jul.
Free article
Abstract
Background: Clinically indistinguishable attacks of acute porphyria occur in acute intermittent porphyria (AIP), hereditary coproporphyria (HCP), and variegate porphyria (VP). There are few evidence-based diagnostic strategies for these disorders.
Methods: The diagnostic sensitivity of mutation detection was determined by sequencing and gene-dosage analysis to search for mutations in 467 sequentially referred, unrelated patients. The diagnostic accuracy of plasma fluorescence scanning, fecal porphyrin analysis, and porphobilinogen deaminase (PBGD) assay was assessed in mutation-positive patients (AIP, 260 patients; VP, 152 patients; HCP, 31 patients).
Results: Sensitivities (95% CI) for mutation detection were as follows: AIP, 98.1% (95.6%-99.2%); HCP, 96.9% (84.3%-99.5%); VP, 100% (95.7%-100%). We identified 5 large deletions in the HMBS gene (hydroxymethylbilane synthase) and one in the CPOX gene (coproporphyrinogen oxidase). The plasma fluorescence scan was positive more often in VP (99% of patients) than in AIP (68%) or HCP (29%). The wavelength of the fluorescence emission peak and the fecal coproporphyrin isomer ratio had high diagnostic specificity and sensitivity for differentiating between AIP, HCP, and VP. DNA analysis followed by PBGD assay in mutation-negative patients had greater diagnostic accuracy for AIP than either test alone.
Conclusions: When PBG excretion is increased, 2 investigations (plasma fluorescence scanning, the coproporphyrin isomer ratio) are sufficient, with rare exceptions, to identify the type of acute porphyria. When the results of PBG, 5-aminolevulinate, and porphyrin analyses are within reference intervals and clinical suspicion that a past illness was caused by an acute porphyria remains high, mutation analysis of the HMBS gene followed by PBGD assay is an effective strategy for diagnosis or exclusion of AIP.
Similar articles
- Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.
Loskove Y, Yasuda M, Chen B, Nazarenko I, Cody N, Desnick RJ. Loskove Y, et al. Mol Genet Metab. 2019 Nov;128(3):352-357. doi: 10.1016/j.ymgme.2018.10.008. Epub 2018 Oct 26. Mol Genet Metab. 2019. PMID: 30385147 - Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
Martinez di Montemuros F, Di Pierro E, Patti E, Tavazzi D, Danielli MG, Biolcati G, Rocchi E, Cappellini MD. Martinez di Montemuros F, et al. Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76. Cell Mol Biol (Noisy-le-grand). 2002. PMID: 12699245 - Digenic inheritance of mutations in the coproporphyrinogen oxidase and protoporphyrinogen oxidase genes in a unique type of porphyria.
van Tuyll van Serooskerken AM, de Rooij FW, Edixhoven A, Bladergroen RS, Baron JM, Joussen S, Merk HF, Steijlen PM, Poblete-Gutiérrez P, te Velde K, Wilson JH, Koole RH, van Geel M, Frank J. van Tuyll van Serooskerken AM, et al. J Invest Dermatol. 2011 Nov;131(11):2249-54. doi: 10.1038/jid.2011.186. Epub 2011 Jul 7. J Invest Dermatol. 2011. PMID: 21734717 - Review: molecular pathogenesis of hepatic acute porphyrias.
Grandchamp B, Puy H, Lamoril J, Deybach JC, Nordmann Y. Grandchamp B, et al. J Gastroenterol Hepatol. 1996 Nov;11(11):1046-52. doi: 10.1111/j.1440-1746.1996.tb00035.x. J Gastroenterol Hepatol. 1996. PMID: 8985829 Review. - Hepatic porphyrias in children.
Elder GH. Elder GH. J Inherit Metab Dis. 1997 Jun;20(2):237-46. doi: 10.1023/a:1005313024076. J Inherit Metab Dis. 1997. PMID: 9211196 Review.
Cited by
- Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks.
Wilson-Baig N, Badminton M, Schulenburg-Brand D. Wilson-Baig N, et al. BJA Educ. 2021 Feb;21(2):66-74. doi: 10.1016/j.bjae.2020.09.005. Epub 2020 Dec 9. BJA Educ. 2021. PMID: 33889432 Free PMC article. Review. No abstract available. - Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M, Ricci A, Cuoghi C, Marchini S, Pietrangelo A, Ventura P. Marcacci M, et al. Orphanet J Rare Dis. 2022 Apr 7;17(1):160. doi: 10.1186/s13023-022-02314-9. Orphanet J Rare Dis. 2022. PMID: 35392955 Free PMC article. Review. - Porphyrias at a glance: diagnosis and treatment.
Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E. Cappellini MD, et al. Intern Emerg Med. 2010 Oct;5 Suppl 1:S73-80. doi: 10.1007/s11739-010-0449-7. Intern Emerg Med. 2010. PMID: 20865478 Review. - Acute intermittent porphyria associated with respiratory failure: a multidisciplinary approach.
Menegueti MG, Gil Cezar AT, Casarini KA, Muniz Cordeiro KS, Basile-Filho A, Martins-Filho OA, Auxiliadora-Martins M. Menegueti MG, et al. Crit Care Res Pract. 2011;2011:283690. doi: 10.1155/2011/283690. Epub 2011 May 11. Crit Care Res Pract. 2011. PMID: 21687623 Free PMC article. - Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, Phillips JD, Naik H, Peter I, Baillargeon G, Bossi K, Gandolfo L, Light C, Bishop D, Desnick RJ. Bonkovsky HL, et al. Am J Med. 2014 Dec;127(12):1233-41. doi: 10.1016/j.amjmed.2014.06.036. Epub 2014 Jul 10. Am J Med. 2014. PMID: 25016127 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous